Duke University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Duke University sits in the top decile of US sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count).
Duke University: 1,725 sponsored US clinical trials, 187 recruiting.
Duke University sponsors 1,725 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 1,244 completed. 175 of these trials are in Phase 3-4 (later-stage) and 311 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
Duke University ranks in the top decile of sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,244 of 1,444 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,725 total, page 23 of 35
Comparison of Combination Therapy vs Single Agent Therapy for Treatment of Urge Incontinence.
NCT02176642
TEA vs. PVB vs. PCA in Liver Resection Surgery
NCT02192879
Changes in fMRI and Neurocognitive Function in Women With Pre-eclampsia
NCT03863639
Adoptive Transfer of Haplo-identical DLI for AML and MDS
NCT02046122
Diabetes Self-Management & Support LIVE
NCT02040038
Impact of Oral Antibiotic Treatment on C. Difficile
NCT02057198
Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD)
NCT02176317
The Effect of Oral Carnitine Supplementation on MRS-derived Mitochondrial Function
NCT02124590
Older Cancer Caregiver Needs Post Hospital Discharge
NCT02099526
Anti-thrombin III (ATIII) vs Placebo in Children (<7mo) Undergoing Open Congenital Cardiac Surgery
NCT02103114
Enhancing Exercise in Breast Cancer Survivors
NCT01849978
Traditional African Healing Ceremony in a U.S. Population
NCT01873482
Optimizing Health Outcomes in Patients With Symptomatic Aortic Valve Disease
NCT02266251
Use of Mobile Technology for Intensive Training in Medication Management
NCT02133560
Health Coaching for Glaucoma Patients
NCT02090777
Trial of Neoadjuvant Ipilimumab Followed by Melphalan Via Isolated Limb Infusion for Patients With Unresectable In-transit Extremity Melanoma
NCT02115243
Prader-Willi Syndrome Macronutrient Study
NCT02011360
Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)
NCT01829256
Family Health History in Diverse Care Settings (FHH)
NCT01956773
Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)
NCT02057939
Testing Methods of Self-persuasion Involving Cigarette Smoking
NCT02069483
Dynamics of the Microbiome in the Premature Infant
NCT02121938
Triceps Surae Trigger Point Size and Muscle Extensibility
NCT02087969
H.O.P.E: Helping Ovarian Cancer Patients Cope
NCT02090582
Brain Connectivity in Age-Related Macular Degeneration
NCT01996215
The Mobile Health Platform
NCT02099513
Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancer
NCT02036918
The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device
NCT02016898
BABY STEPS II: SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit
NCT01995097
Normal Eyelid Sensation Distribution
NCT02059824
Pharmacokinetics of Dexmedetomidine in Children During Cardiopulmonary Bypass (CPB)
NCT02059343
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
NCT02080650
Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease
NCT02080897
Mobile Sensing of Smoking Behavior
NCT02116283
Feeling and Body Investigators for Pediatric Abdominal Pain
NCT02075437
A High Protein Weight Loss Intervention for Sarcopenic Obesity in Women
NCT02033655
The Impact of Early Follow-up on Readmission Rates in AMI Patients
NCT02276456
RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)
NCT02026960
Home Based Exercise Program for Elderly Cancer Patients
NCT01990066
Acute and Chronic Nicotine Modulation of Reinforcement Learning
NCT01830842
Efficacy and Safety of the DASH Diet in Adults With Moderate Chronic Kidney Disease: Pilot Study
NCT02059811
Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy
NCT02040155
Intensive Dysarthria Sessions in Adults and Children With Down Syndrome
NCT01684670
Mobile App Based Personalized Solutions and Tools for Medication Adherence of Rx Pills
NCT02072005
Imaging Lens Deposits in Exfoliation Syndrome
NCT02042703
Bone Marrow Aspirate Concentrate (BMAC) Supplementation for Osteochondral Lesions
NCT02011295
Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer
NCT01717053
Pathways to Cardiovascular Disease Prevention (DCRI Central and Statistical Coordinating Center)
NCT04025125
Who Contributes to the Ordering of CT Scans in Emergency Department Patients?
NCT02040896
Changes in Gut Hormones, Body Composition and Energy Expenditure After Roux-en-Y
NCT02048501
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 136 |
| Phase 2 | 175 |
| Phase 3 | 41 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Duke University pipeline
187 recruiting of 1,725 indexed (11% open); 1,244 completed (72%).
Phase mix: 175 late (III/IV) vs 311 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Duke University: open-pipeline peers nationwide
Peers matched on 1,725 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Duke University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,725 trials (± recruiting share)
- University of California, San Francisco · 1,713 trials · 16% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Carnegie Mellon University · 11% recruiting · 37 trials
- CAMC Health System · 11% recruiting · 28 trials
- UConn Health · 11% recruiting · 178 trials
- Hartford Hospital · 11% recruiting · 75 trials
Related
What to do with this Duke University page
1,725 registered trials is a research-attention snapshot, not an endorsement of Duke University or any single study.
- 187 of Duke University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Duke University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duke University pipeline card: 1,725 registered trials from official public datasets.Report a data error.